Display search results for ** instead (5 products)
05 Oct 2018  |  North America
Companies are Vying for a Higher Market Position in the Early Cancer Screening Market
Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...
24 Aug 2018  |  North America
Optimizing Quality and Efficiency of Healthcare Delivery with AI
The study describes how AI technologies are paired with legacy healthcare IT systems to deal with the complexity & growth of medical data. Frost & Sullivan acknowledges that AI intuitively finds ways to convert these ever-expanding resources into actionable evidence for end users. In this study, Frost & Sullivan has forecast global revenue for prim...
24 Oct 2018  |  North America
A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market
The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...
30 Oct 2018  |  North America
Emerging Use Cases, Revenue, and Industry Savings Potential
Artificial Intelligence (AI) for medical imaging is a reality now. While image analysis applications are the most advanced, adopted, and well-known, there are several other use cases which are probably not as well-known or thought of. Applications across the imaging workflow, beginning with the ordering of images by a physician, scheduling of the s...
12 Dec 2018  |  North America
Innovation-as-a-service Business Model will Accelerate Growth in the Molecular Diagnostic Subsegment
Rapid technological turnaround has become a norm in the life science and in-vitro diagnostic industry. Extrinsic factors such as lack of skilled labor to operate the instrumentation as well as functional factors like demand for very high precision and reproducibility of results are driving this technological evolution. As the instrument efficiency ...